406 related articles for article (PubMed ID: 15912498)
1. OPA1 expression in the normal rat retina and optic nerve.
Ju WK; Misaka T; Kushnareva Y; Nakagomi S; Agarwal N; Kubo Y; Lipton SA; Bossy-Wetzel E
J Comp Neurol; 2005 Jul; 488(1):1-10. PubMed ID: 15912498
[TBL] [Abstract][Full Text] [Related]
2. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
[TBL] [Abstract][Full Text] [Related]
3. Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer.
Aijaz S; Erskine L; Jeffery G; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1667-73. PubMed ID: 15161824
[TBL] [Abstract][Full Text] [Related]
4. OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina.
Pesch UE; Fries JE; Bette S; Kalbacher H; Wissinger B; Alexander C; Kohler K
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4217-25. PubMed ID: 15505078
[TBL] [Abstract][Full Text] [Related]
5. OPA1 expression in the human retina and optic nerve.
Wang AG; Fann MJ; Yu HY; Yen MY
Exp Eye Res; 2006 Nov; 83(5):1171-8. PubMed ID: 16857190
[TBL] [Abstract][Full Text] [Related]
6. OPA1 functions in mitochondria and dysfunctions in optic nerve.
Lenaers G; Reynier P; Elachouri G; Soukkarieh C; Olichon A; Belenguer P; Baricault L; Ducommun B; Hamel C; Delettre C
Int J Biochem Cell Biol; 2009 Oct; 41(10):1866-74. PubMed ID: 19389483
[TBL] [Abstract][Full Text] [Related]
7. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
[TBL] [Abstract][Full Text] [Related]
8. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
[TBL] [Abstract][Full Text] [Related]
9. Expression of janusin (J1-160/180) in the retina and optic nerve of the developing and adult mouse.
Bartsch U; Pesheva P; Raff M; Schachner M
Glia; 1993 Sep; 9(1):57-69. PubMed ID: 8244531
[TBL] [Abstract][Full Text] [Related]
10. OPA1-associated disorders: phenotypes and pathophysiology.
Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
[TBL] [Abstract][Full Text] [Related]
11. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy.
Williams PA; Morgan JE; Votruba M
Brain; 2010 Oct; 133(10):2942-51. PubMed ID: 20817698
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network.
Kamei S; Chen-Kuo-Chang M; Cazevieille C; Lenaers G; Olichon A; Bélenguer P; Roussignol G; Renard N; Eybalin M; Michelin A; Delettre C; Brabet P; Hamel CP
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4288-94. PubMed ID: 16249510
[TBL] [Abstract][Full Text] [Related]
13. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
[TBL] [Abstract][Full Text] [Related]
14. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
[TBL] [Abstract][Full Text] [Related]
15. Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.
Sarzi E; Seveno M; Angebault C; Milea D; Rönnbäck C; Quilès M; Adrian M; Grenier J; Caignard A; Lacroux A; Lavergne C; Reynier P; Larsen M; Hamel CP; Delettre C; Lenaers G; Müller A
Hum Mol Genet; 2016 Jun; 25(12):2539-2551. PubMed ID: 27260406
[TBL] [Abstract][Full Text] [Related]
16. Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity.
Williams PA; Piechota M; von Ruhland C; Taylor E; Morgan JE; Votruba M
Brain; 2012 Feb; 135(Pt 2):493-505. PubMed ID: 22300878
[TBL] [Abstract][Full Text] [Related]
17. OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy.
White KE; Davies VJ; Hogan VE; Piechota MJ; Nichols PP; Turnbull DM; Votruba M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2567-71. PubMed ID: 19234344
[TBL] [Abstract][Full Text] [Related]
18. Is Thy-1 expressed only by ganglion cells and their axons in the retina and optic nerve?
Perry VH; Morris RJ; Raisman G
J Neurocytol; 1984 Oct; 13(5):809-24. PubMed ID: 6210349
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of CNTFRalpha in adult mouse retina and optic nerve following intraorbital nerve crush: evidence for the axonal loss of a trophic factor receptor after injury.
Miotke JA; MacLennan AJ; Meyer RL
J Comp Neurol; 2007 Jan; 500(2):384-400. PubMed ID: 17111380
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.
Heiduschka P; Schnichels S; Fuhrmann N; Hofmeister S; Schraermeyer U; Wissinger B; Alavi MV
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1424-31. PubMed ID: 19834041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
